Daniel Bellus

This inventor holds 39 USPTO granted patents and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Ciba-Geigy Corporation, Circomed LLC, Speedel Pharma Ag. Active years: 1977-2013.

USPTO Granted Patents = 39

% Patents Active = 94.9

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 232(Granted Patents)

Company Filing History:

37 out of 6,858

Ciba-Geigy Corporation

Years Active: 1977-2013

Loading Chart...

Areas of Expertise:

Thienotriazolodiazepine

Apo A

Aryloctanoyl Amides

Tricyclic Imidyl Derivatives

Cyclobutane Compounds

Pyridine Dicarboxylic Acids

Vinylstilbene Compounds

Photocrosslinkable Polymers

Pesticidal Compounds

Plant Growth Influencers

Dihalovinyl Compounds

Photo-Crosslinkable Polyamide

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8569288 - Thienotriazolodiazepine derivatives active on apo A (2013-10-29),

2. 6670507 - Process for the preparation of aryloctanoyl amides (2003-12-30),

3. 4857660 - Certain 1-phenyl-cyclobutane-1,3-dicarboxylic acid type compounds (1989-08-15),

4. 4764640 - Substituted azabicycloheptanes, the use thereof, pharmaceutical (1988-08-16),

5. 4748244 - Process for the preparation of pyridine-2-3-dicarboxylic acid (1988-05-31),

6. 4677129 - Substituted-3-azabicyclo[3.1.1]heptane-2,4-diones useful for treating (1987-06-30),

7. 4487942 - 6,7-Dihydro-5H-benzocycloheptene-8,9-dicarboxylic acid anhydrides (1984-12-11),

8. 4486596 - 2,3-Dihydro-1-benzoxepine-4,5-dicarboxylic acid anhydrides (1984-12-04),

9. 4440694 - Process for the production of vinylstilbene compounds (1984-04-03),

10. 4424366 - Tricyclic imidyl derivatives (1984-01-03),

11. 4423231 - Tricyclic imidyl derivatives (1983-12-27),

12. 4418200 - Tricyclic imidyl derivatives (1983-11-29),

13. 4418199 - Tricyclic imidyl derivatives (1983-11-29),

14. 4417058 - Tricyclic imidyl derivatives (1983-11-22),

15. 4414394 - Tricyclic imidyl derivatives (1983-11-08),

Title: Daniel Bellus: A Trailblazer in Innovation

Introduction:

Daniel Bellus, a renowned inventor based in Riehen, CH, has made significant contributions to the world of technology with his creative and sustainable solutions. With 39 patents to his name, he continues to be a driving force in the field of invention.

Latest Patents:

Among his latest patents is the development of Thienotriazolodiazepine derivatives active on apo A. These compounds play a crucial role in the treatment and prevention of atherosclerotic artery diseases, including myocardial infarction, stroke, and Alzheimer's disease. His innovative approach to pharmaceutical compositions has paved the way for groundbreaking advancements in healthcare.

Career Highlights:

Throughout his career, Daniel Bellus has lent his expertise to esteemed companies such as Ciba-Geigy Corporation and Circomed LLC. His dedication to innovation and his ability to think outside the box have led to the successful implementation of novel ideas and technologies in various industries.

Collaborations:

During his professional journey, Daniel Bellus has collaborated with talented individuals such as Hans Zweifel and Walter Schilling. Together, they have worked on projects that have revolutionized the way we approach complex challenges in science and technology.

Conclusion:

In conclusion, Daniel Bellus stands as a beacon of innovation, constantly pushing the boundaries of what is possible in the world of technology. His passion for creating a more sustainable future through inventive solutions continues to inspire generations of inventors and innovators worldwide. Daniel Bellus's exemplary work serves as a testament to the power of creativity and perseverance in driving positive change in society.